Chronic Fatigue Syndrome Shows Distinct Metabolomic Signatures, UCSD Study Says | GenomeWeb

NEW YORK (GenomeWeb) – A new metabolomics study of patients with chronic fatigue syndrome suggests a breakthrough in the understanding of the condition, with potential to offer the first biomarker-based diagnostic test.

Metabolic profiles from blood plasma of CFS patients indicate that the condition, which has resisted characterization, looks a lot like a post-infection or post-stress metabolic state that has failed to return to normal.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.